SCHEMBL7550682

SCHEMBL7550682

N#CC1CCN(CCn2cc(-c3cncc(-c4ccc(Cl)cc4)c3)c3cc(Cl)ccc32)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.44
FLT1 P17948 3/20 0.43
FLT4 P35916 3/20 0.43
CHEK1 O14757 1/20 0.36
ACHE P22303 1/20 0.36
CHRNB1 P11230 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNB3 Q05901 1/20 0.35
NFATC1 O95644 2/20 0.34
GSK3B P49841 2/20 0.34
DYRK1A Q13627 2/20 0.34
EGLN1 Q9GZT9 1/20 0.33
KRAS P01116 1/20 0.33
CHRM1 P11229 1/20 0.32
HTR2A P28223 1/20 0.32
MCHR1 Q99705 1/20 0.32
RAB9A P51151 1/20 0.32
PRMT5 O14744 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7509366 0.94 KDR (0.47) KDRFLT1FLT4CHEK1ACHE
SCHEMBL7551299 0.93 KDR (0.44) KDRFLT1FLT4CHEK1ACHE
SCHEMBL7545884 0.92 KDR (0.40) KDRFLT1FLT4CHEK1ACHE
SCHEMBL7548831 0.92 KDR (0.44) KDRFLT1FLT4NFATC1GSK3B
SCHEMBL7557245 0.92 KDR (0.54) KDRFLT1FLT4CHEK1ACHE
SCHEMBL7551238 0.90 KDR (0.40) KDRFLT1FLT4CHEK1ACHE
SCHEMBL7976915 0.89 KDR (0.59) KDRFLT1FLT4NFATC1GSK3B
SCHEMBL7550379 0.87 KDR (0.47) KDRFLT1FLT4CHEK1ACHE
SCHEMBL7547917 0.86 KDR (0.40) KDRFLT1FLT4CHRNB1CHRNB2
SCHEMBL7555601 0.85 KDR (0.58) KDRFLT1FLT4CHRNB1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed